Related Experiment Video
Updated: Jan 18, 2026
10:42
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
Published on: June 15, 2021
5.5K
Integrating Macrophages into Human-Engineered Cardiac Tissue
1Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Cells
|September 13, 2025
Summary
Engineered cardiac tissues using human stem cells offer advanced models for heart disease research. Integrating immune cells like macrophages improves these models for better drug development and understanding cardiac injury.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Immunology
Background:
- Heart disease is a major global health burden, driving the need for better preclinical models.
- Human-based engineered cardiac tissues (hECTs) are emerging as promising alternatives to traditional animal models.
- The role of the immune system, especially macrophages, in myocardial injury is increasingly recognized.
Purpose of the Study:
- To review methods for deriving macrophages from human pluripotent stem cells (hPSCs).
- To discuss the integration of these macrophages into hECTs.
- To highlight challenges and opportunities in creating advanced cardiac models.
Main Methods:
- Derivation of macrophages from hPSCs.
- Incorporation of hPSCs-derived macrophages into engineered cardiac tissue constructs.
- Review of current literature on hECTs and immune cell integration.
Main Results:
- Successful derivation of macrophages from hPSCs.
- Advancements in integrating immune cells into 3D cardiac constructs.
- Identification of challenges such as immune cell infiltration and maintaining tissue architecture.
Conclusions:
- Integrating macrophages into hECTs enhances their potential as sophisticated tools for cardiac research.
- These advanced models can aid in unraveling cardiac pathology and developing targeted therapies.
- Future work should focus on overcoming challenges in modeling complex cardiac microenvironments.
